Cardiac arrhythmia and injury induced in rats by burst and pulsed mode ultrasound with a gas body contrast agent

Journal of Ultrasound in Medicine

Volumn 28, Issue 11, 2009, Pages 1519-1526

  Miller, Douglas L ^a   Dou, Chunyan ^a   Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Arrhythmia; Contrast agent adverse effects; Gas body activation; Myocardial contrast echocardiography; Ultrasonic cavitation biology

Indexed keywords

DISEASES; ELECTROCARDIOGRAPHY; PHYSICAL THERAPY; RATS;

ADVERSE EFFECT; ARRHYTHMIA; CONTRAST ECHOCARDIOGRAPHY; DIAGNOSTIC ULTRASOUND; ELECTROCARDIOGRAM SIGNAL; MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY; ULTRASONIC CAVITATION; ULTRASOUND CONTRAST AGENT;

ECHOCARDIOGRAPHY;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUOROCARBON; PERFLUTREN;

ANIMAL; ARTICLE; GAS; HAIRLESS RAT; HEART ARRHYTHMIA; HEART INJURY; PATHOPHYSIOLOGY; RAT; ULTRASOUND;

ANIMALS; ARRHYTHMIAS, CARDIAC; CONTRAST MEDIA; FLUOROCARBONS; GASES; HEART INJURIES; RATS; RATS, HAIRLESS; SONICATION;

EID: 73949151992     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2009.28.11.1519     Document Type: Article

References (12)

1. Miller DL, Averkiou MA, Brayman AA, et al. Bioeffects considerations for diagnostic ultrasound contrast agents. J Ultrasound Med 2008; 27:611-632.
2. van Der Wouw PA, Brauns AC, Bailey SE, Powers JE, Wilde AA. Premature ventricular contractions during triggered imaging with ultrasound contrast. J Am Soc Echocardiogr 2000; 13:288-294.
3. Chapman S, Windle J, Xie F, McGrain A, Porter TR. Incidence of cardiac arrhythmias with therapeutic versus diagnostic ultrasound and intravenous microbubbles. J Ultrasound Med 2005; 24:1099-1107.
4. Li P, Cao LQ, Dou CY, Armstrong WR, Miller DL. Impact of myocardial contrast echocardiography on vascular permeability: an in vivo dose response study of delivery mode, ultrasound power and contrast dose. Ultrasound Med Biol 2003; 29:1341-1349.
5. Miller DL, Driscoll EM, Dou C, Armstrong WF, Lucchesi BR. Microvascular permeabilization and cardiomyocyte injury provoked by myocardial contrast echocardiography in a canine model. J Am Coll Cardiol 2006; 47:1464-1468.
6. Miller DL, Li P, Gordon D, Armstrong WF. Histological characterization of microlesions induced by myocardial contrast echocardiography. Echocardiography 2005; 22:25-34.
7. Miller DL, Li P, Dou C, Gordon D, Edwards CA, Armstrong WF. Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats. Radiology 2005; 237: 137-143.
8. Zachary JF, Hartleben SA, Frizzell LA, O'Brien WD Jr. Arrhythmias in rat hearts exposed to pulsed ultrasound after intravenous injection of a contrast agent. J Ultrasound Med 2002; 21:1347-1356.
9. Carstensen EL, Gracewski S, Dalecki D. The search for cavitation in vivo. Ultrasound Med Biol 2000; 26:1377-1385.
10. Porter TR, Everbach C, Kricsfeld D, Xie F. Myocardial cavitational activity during continuous infusion and bolus intravenous injections of perfluorocarbon-containing microbubbles. J Am Soc Echocardiogr 2001; 14:618-625.
11. Hamlin RL. Non-drug-related electrocardiographic features in animal models in safety pharmacology. J Pharmacol Toxicol Methods 2005; 52:60-76.
12. Miller DL, Dou C, Wiggins RC. Simulation of diagnostic ultrasound image pulse sequences in cavitation bioeffects research. J Acoust Soc Am 2007; 122:2002-2008.